Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,476 | 225 | 87.7% |
| Travel and Lodging | $716.48 | 1 | 11.5% |
| Education | $55.00 | 1 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| NeoTract Inc. | $1,179 | 9 | $0 (2020) |
| Astellas Pharma US Inc | $782.67 | 51 | $0 (2024) |
| Boston Scientific Corporation | $701.38 | 11 | $0 (2024) |
| Janssen Biotech, Inc. | $381.25 | 16 | $0 (2022) |
| Dendreon Pharmaceuticals LLC | $319.97 | 9 | $0 (2024) |
| Allergan, Inc. | $310.69 | 16 | $0 (2021) |
| ACCORD HEALTHCARE, INC. | $231.09 | 4 | $0 (2023) |
| PFIZER INC. | $182.61 | 13 | $0 (2019) |
| Bayer Healthcare Pharmaceuticals Inc. | $167.34 | 9 | $0 (2024) |
| Olympus America Inc. | $164.26 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $544.59 | 21 | UROGEN PHARMA, INC. ($158.45) |
| 2023 | $871.40 | 23 | ACCORD HEALTHCARE, INC. ($231.09) |
| 2022 | $427.42 | 17 | Janssen Biotech, Inc. ($103.79) |
| 2021 | $589.03 | 23 | BOSTON SCIENTIFIC CORPORATION ($203.06) |
| 2020 | $546.62 | 16 | Allergan, Inc. ($180.16) |
| 2019 | $754.78 | 40 | Boston Scientific Corporation ($142.63) |
| 2018 | $1,876 | 56 | NeoTract Inc. ($969.04) |
| 2017 | $636.87 | 31 | Astellas Pharma US Inc ($204.38) |
All Payment Transactions
227 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/15/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $15.48 | General |
| Category: Oncology | ||||||
| 11/13/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $17.97 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 10/30/2024 | Axonics, Inc. | Axonics (Device) | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: Urology | ||||||
| 10/24/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $133.32 | General |
| Category: UROTHELIAL CANCER | ||||||
| 10/23/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $34.48 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 10/23/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $14.61 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 10/11/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $20.49 | General |
| Category: Oncology | ||||||
| 09/18/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $25.13 | General |
| Category: UROTHELIAL CANCER | ||||||
| 09/06/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: Oncology | ||||||
| 07/26/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $21.03 | General |
| Category: Oncology | ||||||
| 07/18/2024 | Boston Scientific Corporation | AMS 700 (Device) | Food and Beverage | In-kind items and services | $20.71 | General |
| Category: AMS 700_URO | ||||||
| 06/26/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $19.77 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 05/30/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $20.09 | General |
| Category: Oncology | ||||||
| 05/10/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $17.44 | General |
| 04/24/2024 | Alnylam Pharmaceuticals Inc. | OXLUMO (Drug) | Food and Beverage | In-kind items and services | $26.71 | General |
| Category: Genetic Disease | ||||||
| 03/08/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $26.59 | General |
| Category: Oncology | ||||||
| 02/16/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $20.51 | General |
| Category: Oncology | ||||||
| 02/02/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $15.08 | General |
| Category: UROLOGY | ||||||
| 01/19/2024 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $22.56 | General |
| Category: Urology | ||||||
| 01/15/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $18.38 | General |
| Category: Oncology | ||||||
| 01/05/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $22.88 | General |
| Category: ONCOLOGY | ||||||
| 12/21/2023 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Interventional Urology | ||||||
| 12/04/2023 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $21.47 | General |
| Category: ONCOLOGY | ||||||
| 10/31/2023 | Boston Scientific Corporation | SpaceOAR VUE System - 10mL (Device) | Food and Beverage | In-kind items and services | $94.78 | General |
| Category: SpaceOAR VUE_URO | ||||||
| 10/26/2023 | Olympus America Inc. | iTIND System (Device) | Food and Beverage | In-kind items and services | $129.39 | General |
| Category: Urology Gynecology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 25 | 2,080 | 5,586 | $769,513 | $194,452 |
| 2022 | 32 | 2,215 | 7,081 | $723,289 | $211,774 |
| 2021 | 31 | 1,991 | 5,833 | $669,136 | $195,673 |
| 2020 | 31 | 1,758 | 4,292 | $551,177 | $148,178 |
All Medicare Procedures & Services
124 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 489 | 676 | $221,174 | $57,338 | 25.9% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 27 | 249 | $174,300 | $33,858 | 19.4% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 97 | 111 | $80,037 | $20,004 | 25.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 233 | 275 | $68,199 | $16,278 | 23.9% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 55 | 276 | $35,052 | $13,222 | 37.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 35 | 53 | $22,295 | $7,062 | 31.7% |
| 74178 | Ct scan of abdomen and pelvis before and after contrast | Office | 2023 | 23 | 23 | $18,212 | $6,145 | 33.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 54 | 54 | $21,530 | $5,645 | 26.2% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 46 | 137 | $13,152 | $5,001 | 38.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 59 | 59 | $18,363 | $4,524 | 24.6% |
| 99426 | Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 17 | 82 | $10,250 | $3,839 | 37.4% |
| 74176 | Ct scan of abdomen and pelvis without contrast | Office | 2023 | 24 | 24 | $10,359 | $3,221 | 31.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 262 | 323 | $4,845 | $2,713 | 56.0% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 24 | 25 | $10,398 | $2,641 | 25.4% |
| 76770 | Complete ultrasound scan behind abdominal cavity | Office | 2023 | 24 | 27 | $7,054 | $2,158 | 30.6% |
| 55700 | Biopsy of prostate gland | Facility | 2023 | 18 | 18 | $11,220 | $1,717 | 15.3% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 192 | 220 | $8,162 | $1,638 | 20.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 16 | 16 | $5,990 | $1,615 | 27.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 13 | 23 | $5,382 | $1,412 | 26.2% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 28 | 46 | $4,697 | $1,122 | 23.9% |
| 51700 | Simple bladder irrigation and/or instillation | Office | 2023 | 17 | 18 | $4,156 | $1,061 | 25.5% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2023 | 12 | 16 | $2,895 | $761.12 | 26.3% |
| 81003 | Automated urinalysis test | Office | 2023 | 250 | 293 | $2,930 | $638.00 | 21.8% |
| 76872 | Ultrasound scan of pelvic region through rectum | Facility | 2023 | 18 | 18 | $6,208 | $428.66 | 6.9% |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 2023 | 24 | 2,501 | $2,376 | $298.41 | 12.6% |
About Dr. Steven Schneider, MD
Dr. Steven Schneider, MD is a Urology healthcare provider based in Chesterfield, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/11/2009. The National Provider Identifier (NPI) number assigned to this provider is 1598997439.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Steven Schneider, MD has received a total of $6,247 in payments from pharmaceutical and medical device companies, with $544.59 received in 2024. These payments were reported across 227 transactions from 48 companies. The most common payment nature is "Food and Beverage" ($5,476).
As a Medicare-enrolled provider, Schneider has provided services to 8,044 Medicare beneficiaries, totaling 22,792 services with total Medicare billing of $750,076. Data is available for 4 years (2020–2023), covering 124 distinct procedure/service records.
Practice Information
- Specialty Urology
- Other Specialties Urology
- Location Chesterfield, MO
- Active Since 08/11/2009
- Last Updated 12/01/2021
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1598997439
Products in Payments
- UROLIFT (Device) $987.02
- XTANDI (Drug) $410.55
- PROVENGE (Drug) $396.88
- Erleada (Drug) $261.25
- BOTOX (Biological) $254.20
- UroLift (Device) $239.98
- Myrbetriq (Drug) $234.35
- CAMCEVI (Drug) $231.09
- GENERAL - KIDNEY STONE DISEASE (Device) $190.46
- MYRBETRIQ (Drug) $168.83
- JELMYTO (Drug) $158.45
- Prolia (Biological) $135.27
- iTIND System (Device) $129.39
- ERLEADA (Drug) $120.51
- Noctiva (Drug) $118.56
- NOCDURNA (Drug) $112.23
- GENERAL PAIN MANAGEMENT (Device) $101.53
- LITHOVUE (Device) $101.53
- Nubeqa (Drug) $98.01
- KEYTRUDA (Biological) $97.78
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Chesterfield
Dr. Cathy Naughton, Md, MD
Urology — Payments: $30,035
David Bryan, Md, MD
Urology — Payments: $23,173
John Mccarthy, Md, MD
Urology — Payments: $9,126
Nimrod Barashi Gozal, Md, MD
Urology — Payments: $4,667
Mrs. Angela Alt, Md, MD
Urology — Payments: $139.03
Ronald Deguerre, Md, MD
Urology — Payments: $49.96